Overview

A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via the TWISTHALER® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the dose response relationship among four doses of indacaterol as well as placebo delivered via the TWISTHALER® device.
Phase:
Phase 2
Details
Lead Sponsor:
Novartis
Collaborator:
Schering-Plough
Treatments:
Albuterol
Formoterol Fumarate